AT9283 Completed Phase 1 Trials for Unspecified Childhood Solid Tumor, Protocol Specific Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00985868AT9283 in Children and Adolescents With Relapsed and Refractory Solid Tumors